Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
4.000
+0.250 (6.67%)
At close: Sep 5, 2025, 4:00 PM
4.050
+0.050 (1.25%)
After-hours: Sep 5, 2025, 7:59 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $123.95 million as of September 5, 2025. Its market cap has decreased by -16.30% in one year.
Market Cap
123.95M
Enterprise Value
75.74M
1-Year Change
-16.30%
Ranking
Category
Stock Price
$4.00
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $123.95M, a decrease of -65.19%. That is a compound annual growth rate of -52.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 116.20M | 35.27% |
| Dec 31, 2024 | 85.90M | -75.88% |
| Apr 11, 2024 | 356.10M | - |
View and export this data all the way back to 2024. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |